Menu
Currency
GWAS Study

Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response.

Esposito M, Minnai F, Copetti M et al.

38575714 PubMed ID
GWAS Study Type
1351 Participants
47 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

EM
Esposito M
MF
Minnai F
CM
Copetti M
MG
Miscio G
PR
Perna R
PA
Piepoli A
DV
De Vincentis G
BM
Benvenuto M
DP
D'Addetta P
CS
Croci S
BM
Baldassarri M
BM
Bruttini M
FC
Fallerini C
BR
Brugnoni R
CP
Cavalcante P
BF
Baggi F
CE
Corsini EMG
CE
Ciusani E
AF
Andreetta F
DT
Dragani TA
FM
Fratelli M
CM
Carella M
MR
Mantegazza RE
RA
Renieri A
CF
Colombo F
Chapter II

Abstract

Summary of the research findings

Since the beginning of the anti-COVID-19 vaccination campaign, it has become evident that vaccinated subjects exhibit considerable inter-individual variability in the response to the vaccine that could be partly explained by host genetic factors. A recent study reported that the immune response elicited by the Oxford-AstraZeneca vaccine in individuals from the United Kingdom was influenced by a specific allele of the human leukocyte antigen gene HLA-DQB1.

1,351 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

1351
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Italy
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.